Your browser doesn't support javascript.
loading
Safety and efficacy of cabozantinib for patients with advanced hepatocellular carcinoma who advanced to Child-Pugh B liver function at study week 8: a retrospective analysis of the CELESTIAL randomised controlled trial.
El-Khoueiry, Anthony B; Meyer, Tim; Cheng, Ann-Lii; Rimassa, Lorenza; Sen, Suvajit; Milwee, Steven; Kelley, Robin Kate; Abou-Alfa, Ghassan K.
Afiliação
  • El-Khoueiry AB; USC Norris Comprehensive Cancer Center, Los Angeles, CA, USA. elkhouei@med.usc.edu.
  • Meyer T; Royal Free Hospital, University College London, London, UK.
  • Cheng AL; National Taiwan University Hospital, Taipei, Taiwan.
  • Rimassa L; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Sen S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Milwee S; Exelixis, Inc, Alameda, CA, USA.
  • Kelley RK; Exelixis, Inc, Alameda, CA, USA.
  • Abou-Alfa GK; UCSF Helen Diller Family Comprehensive Cancer Center, CA, San Francisco, USA.
BMC Cancer ; 22(1): 377, 2022 Apr 09.
Article em En | MEDLINE | ID: mdl-35397508
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Idioma: En Ano de publicação: 2022 Tipo de documento: Article